EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis
Authors
Keywords
Galectin-9, EZH2, Hepatocellular carcinoma, Proliferation, Metastasis
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 37, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-09
DOI
10.1186/s13046-017-0670-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Galectin-9: Diverse roles in hepatic immune homeostasis and inflammation
- (2017) Lucy Golden-Mason et al. HEPATOLOGY
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Interferon–microRNA signalling drives liver precancerous lesion formation and hepatocarcinogenesis
- (2016) Yingcheng Yang et al. GUT
- Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review)
- (2016) Jingyu Wang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Tim-3 suppression combined with TLR3 activation enhances antiviral immune response in patients with chronic HCV infection
- (2016) Yue-min Nan et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Targeting EZH2 and PRC2 dependence as novel anticancer therapy
- (2015) Bowen Xu et al. EXPERIMENTAL HEMATOLOGY
- Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo
- (2015) KOJI FUJITA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction
- (2015) Ende Zhao et al. NATURE IMMUNOLOGY
- miRWalk2.0: a comprehensive atlas of microRNA-target interactions
- (2015) Harsh Dweep et al. NATURE METHODS
- microRNA-22 downregulation of galectin-9 influences lymphocyte apoptosis and tumor cell proliferation in liver cancer
- (2015) QIANQIAN YANG et al. ONCOLOGY REPORTS
- Galectin-9 is Involved in Immunosuppression Mediated by Human Bone Marrow-derived Clonal Mesenchymal Stem Cells
- (2015) Si-na Kim et al. Immune Network
- Cancer Cells Hijack PRC2 to Modify Multiple Cytokine Pathways
- (2015) Mohamed Abou El Hassan et al. PLoS One
- EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer
- (2015) Swathi Chinaranagari et al. Oncotarget
- Inhibition enhancer of zeste homologue 2 promotes senescence and apoptosis induced by doxorubicin inp53mutant gastric cancer cells
- (2014) J. Bai et al. CELL PROLIFERATION
- EZH2 Represses Target Genes through H3K27-Dependent and H3K27-Independent Mechanisms in Hepatocellular Carcinoma
- (2014) Shu-Bin Gao et al. MOLECULAR CANCER RESEARCH
- miRDB: an online resource for microRNA target prediction and functional annotations
- (2014) Nathan Wong et al. NUCLEIC ACIDS RESEARCH
- Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation
- (2013) Friederike Gieseke et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Polycomb Protein Ezh2 Regulates Differentiation and Plasticity of CD4+ T Helper Type 1 and Type 2 Cells
- (2013) Damon J. Tumes et al. IMMUNITY
- Intestinal Epithelium-Derived Galectin-9 Is Involved in the Immunomodulating Effects of Nondigestible Oligosaccharides
- (2013) Sander de Kivit et al. Journal of Innate Immunity
- Galectin-9 Acts as a Prognostic Factor with Antimetastatic Potential in Hepatocellular Carcinoma
- (2012) Zhao-Yang Zhang et al. Asian Pacific Journal of Cancer Prevention
- Polycomb Protein EZH2 Regulates Tumor Invasion via the Transcriptional Repression of the Metastasis Suppressor RKIP in Breast and Prostate Cancer
- (2012) G. Ren et al. CANCER RESEARCH
- Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis
- (2012) Sandy Leung-Kuen Au et al. HEPATOLOGY
- Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
- (2012) Hang Li et al. HEPATOLOGY
- MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha
- (2012) H Zhang et al. ONCOGENE
- EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin Signaling
- (2011) Chun-Ju Chang et al. CANCER CELL
- Dual biological effects of the cytokines interleukin-10 and interferon-γ
- (2011) Cailin Moira Wilke et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Galectin-9 Protein Expression in Endothelial Cells Is Positively Regulated by Histone Deacetylase 3
- (2011) Saydul Alam et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer
- (2011) H Taniguchi et al. ONCOGENE
- T-Cell Immunoglobulin Mucin-3 Determines Severity of Liver Ischemia/Reperfusion Injury in Mice in a TLR4-Dependent Manner
- (2010) Yoichiro Uchida et al. GASTROENTEROLOGY
- Ezh2 Orchestrates Gene Expression for the Stepwise Differentiation of Tissue-Specific Stem Cells
- (2009) Elena Ezhkova et al. CELL
- Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: A potent therapeutic tool for Th1- and/or Th17-mediated skin inflammation
- (2009) Haruna Niwa et al. CLINICAL IMMUNOLOGY
- Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation
- (2008) Yutaka Kondo et al. NATURE GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now